Application 011552

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001STELAZINETRIFLUOPERAZINE HYDROCHLORIDETABLET;ORALEQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002STELAZINETRIFLUOPERAZINE HYDROCHLORIDETABLET;ORALEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003STELAZINETRIFLUOPERAZINE HYDROCHLORIDETABLET;ORALEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004STELAZINETRIFLUOPERAZINE HYDROCHLORIDETABLET;ORALEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005STELAZINETRIFLUOPERAZINE HYDROCHLORIDEINJECTABLE;INJECTIONEQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
006STELAZINETRIFLUOPERAZINE HYDROCHLORIDECONCENTRATE;ORALEQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
40672SUPPL2003-02-04
269SUPPL2001-04-03